SHARON BENZENO

Insider Reports History

Location
Seattle, WA
Signature
/s/ Sharon Benzeno by Kyle Piskel, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by SHARON BENZENO:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adaptive Biotechnologies Corp Chief Commercial Ofc Imm Med Common Stock 296,791 $5,000,928 $16.85 04 Dec 2025 Direct
Adaptive Biotechnologies Corp Chief Commercial Ofc Imm Med Stock Option (right to buy) 112,247 04 Dec 2025 Direct

Insider Reports Filed by SHARON BENZENO

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADPT Adaptive Biotechnologies Corp 04 Dec 2025 7 -$108,542 4 Chief Commercial Ofc Imm Med 08 Dec 2025, 20:00
ADPT Adaptive Biotechnologies Corp 20 Nov 2025 18 -$5,679,466 4 Chief Commercial Ofc Imm Med 24 Nov 2025, 21:39
ADPT Adaptive Biotechnologies Corp 04 Mar 2025 4 -$311,792 4 Chief Commercial Ofc Imm Med 06 Mar 2025, 19:21
ADPT Adaptive Biotechnologies Corp 04 Mar 2024 4 -$100,994 4 Chief Commercial Ofc Imm Med 06 Mar 2024, 19:42
ADPT Adaptive Biotechnologies Corp 06 Mar 2023 3 -$100,689 4 Chief Commercial Ofc Imm Med 08 Mar 2023, 19:02
ADPT Adaptive Biotechnologies Corp 04 Mar 2022 3 -$32,067 4 Chief Business Development Off 08 Mar 2022, 20:01